Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,850 | 34 | 59.6% |
| Consulting Fee | $8,200 | 4 | 13.3% |
| Food and Beverage | $8,176 | 377 | 13.2% |
| Honoraria | $6,650 | 3 | 10.8% |
| Travel and Lodging | $1,919 | 13 | 3.1% |
| Education | $47.73 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $31,965 | 173 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $16,995 | 89 | $0 (2020) |
| SK Life Science, Inc. | $9,630 | 39 | $0 (2024) |
| LivaNova USA, Inc. | $463.68 | 4 | $0 (2023) |
| ARGENX US, INC. | $357.07 | 14 | $0 (2024) |
| Celgene Corporation | $349.20 | 22 | $0 (2024) |
| Neurelis, Inc. | $253.60 | 3 | $0 (2024) |
| ABBVIE INC. | $246.01 | 15 | $0 (2024) |
| Eisai Inc. | $232.70 | 15 | $0 (2023) |
| Biogen, Inc. | $228.74 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,209 | 61 | UCB, Inc. ($458.22) |
| 2023 | $1,657 | 79 | UCB, Inc. ($508.17) |
| 2022 | $747.34 | 46 | SK Life Science, Inc. ($161.71) |
| 2021 | $5,551 | 38 | SK Life Science, Inc. ($2,829) |
| 2020 | $21,627 | 45 | UCB, Inc. ($8,619) |
| 2019 | $6,055 | 53 | UCB, Inc. ($3,094) |
| 2018 | $16,357 | 62 | UCB, Inc. ($11,620) |
| 2017 | $8,637 | 49 | UCB, Inc. ($5,006) |
All Payment Transactions
433 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $10.57 | General |
| Category: Neurology | ||||||
| 12/12/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Neurology | ||||||
| 12/06/2024 | SpringWorks Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $17.08 | General |
| 11/15/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Neurology | ||||||
| 11/08/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Neurology | ||||||
| 10/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Neurology | ||||||
| 10/29/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.48 | General |
| 10/28/2024 | Aucta Pharmaceuticals, Inc. | Motpoly XR (Drug) | Food and Beverage | In-kind items and services | $9.25 | General |
| Category: Central Nervous System | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Neurology | ||||||
| 10/16/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $110.77 | General |
| Category: Neurology | ||||||
| 10/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Neurology | ||||||
| 10/07/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Neurology | ||||||
| 09/10/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Rare Disease | ||||||
| 09/06/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Neurology | ||||||
| 08/23/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Neurology | ||||||
| 08/15/2024 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $18.79 | General |
| 08/09/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Neurology | ||||||
| 08/02/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: Neurology | ||||||
| 08/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.48 | General |
| Category: Neuroscience | ||||||
| 07/30/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Neurology | ||||||
| 07/18/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: Neurology | ||||||
| 07/11/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $15.59 | General |
| 06/28/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: Neurology | ||||||
| 06/17/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Neurology | ||||||
| 06/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 400 | 471 | $199,055 | $47,578 |
| 2022 | 13 | 428 | 502 | $187,630 | $43,444 |
| 2021 | 11 | 416 | 563 | $211,845 | $52,583 |
| 2020 | 11 | 426 | 533 | $207,535 | $50,901 |
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 90 | $31,965 | $9,154 | 28.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 53 | 58 | $35,700 | $8,423 | 23.6% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2023 | 36 | 47 | $32,780 | $8,228 | 25.1% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Facility | 2023 | 28 | 34 | $17,795 | $4,212 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 37 | $16,390 | $4,013 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 49 | 54 | $23,420 | $3,872 | 16.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2023 | 64 | 64 | $12,040 | $3,076 | 25.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 22 | 22 | $13,340 | $2,581 | 19.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 27 | 33 | $7,755 | $2,232 | 28.8% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 17 | 17 | $5,555 | $1,206 | 21.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 13 | 15 | $2,315 | $581.10 | 25.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 69 | 85 | $36,935 | $6,365 | 17.2% |
| 95720 | Measurement of brain wave activity with video (veeg), 12-26 hours with review and report by health care professional | Facility | 2022 | 26 | 35 | $24,500 | $6,282 | 25.6% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 59 | 62 | $20,450 | $5,322 | 26.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 61 | 87 | $20,425 | $5,200 | 25.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 30 | 33 | $14,580 | $3,848 | 26.4% |
| 95723 | Measurement of brain wave activity (eeg), 61-84 hours with health care professional review and report | Facility | 2022 | 16 | 18 | $15,365 | $3,767 | 24.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 28 | 39 | $13,045 | $3,428 | 26.3% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Facility | 2022 | 59 | 61 | $11,555 | $3,021 | 26.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $7,880 | $1,652 | 21.0% |
| 95719 | Measurement of brain wave activity (eeg), 12-26 hours with health care professional review and report | Facility | 2022 | 13 | 13 | $6,810 | $1,637 | 24.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 15 | 15 | $5,760 | $1,084 | 18.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 21 | 23 | $7,100 | $1,044 | 14.7% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 17 | 17 | $3,225 | $794.22 | 24.6% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2021 | 28 | 63 | $44,415 | $11,503 | 25.9% |
About Dr. Wei Ma, MD
Dr. Wei Ma, MD is a Neurology healthcare provider based in Edison, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1063412310.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Wei Ma, MD has received a total of $61,842 in payments from pharmaceutical and medical device companies, with $1,209 received in 2024. These payments were reported across 433 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($36,850).
As a Medicare-enrolled provider, Ma has provided services to 1,670 Medicare beneficiaries, totaling 2,069 services with total Medicare billing of $194,506. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Other Specialties Clinical Neurophysiology
- Location Edison, NJ
- Active Since 07/28/2005
- Last Updated 05/22/2008
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1063412310
Products in Payments
- Briviact (Drug) $23,107
- APTIOM (Drug) $17,035
- Cenobamate (Drug) $6,400
- XCOPRI (Drug) $2,714
- Vimpat (Drug) $2,431
- VNS Therapy (Device) $462.64
- ZEPOSIA (Drug) $348.05
- VYVGART (Drug) $279.13
- VALTOCO (Drug) $253.60
- Fycompa (Drug) $214.97
- Fintepla (Drug) $195.81
- KESIMPTA (Drug) $164.56
- ULTOMIRIS (Biological) $151.54
- SPINRAZA (Biological) $132.60
- Zilbrysq (Drug) $131.84
- Vemlidy (Drug) $113.55
- QULIPTA (Drug) $109.01
- ACTIVA (Device) $92.02
- BOTOX (Biological) $88.99
- VYVGART HYTRULO (Drug) $77.94
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Edison
Dr. Marina Sobol, M.d, M.D
Neurology — Payments: $69,571
Dr. Siddharth Kapoor, Md, MD
Neurology — Payments: $50,944
Philip Hanna, Md, MD
Neurology — Payments: $21,708
Dr. Adel Aziz, Md, MD
Neurology — Payments: $19,724
Dr. Lewis Milrod, M.d, M.D
Neurology — Payments: $19,295
Jacqueline Cristini, Pa-C, PA-C
Neurology — Payments: $19,079